FORMA Therapeutics
IPO News: Forma Therapeutics File $150mm IPO
FORMA Therapeutics

Forma Therapeutics


Size:  $150mm

Bookrunners:  JEFF | LEER | CS

Major Holders:  RA Capital | Novartis Bioventures | Baker Brothers | Lily Ventures

Description:  Forma Therapeutics clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics to transform the lives of patients with rare hematologic diseases and cancers


Reference Link:  S-1